You are here
- Home
- Therapy Areas
- Respiratory/Inflammation
A 4 Week Study to Investigate the Safety and Tolerability of AZD5069 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (CIRRUS)
- Disease
- chronic obstructive pulmonary disease
- Drug Name
- AZD5069
- Generic Name
- AZD5069
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- II
- Start Date
- Nov 22, 2010
- Study Name
- D3550C00002
- Study Id
- D3550C00002
- ClinicalTrials.gov ID
- NCT01233232
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
